Showing results (211-220 of 268) with videos related to
Sort By:
Pageof 27
Journal of Cancer Research and Clinical Oncology|March 31, 2023
Two decades of gastric and gastroesophageal junction cancer surgeryPatrick S Plum, Aylin Pamuk, Atakan G Barutcu, et al.The Oncologist|August 19, 2023
Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal CancerEric Van Cutsem, Rona Yaeger, Jean-Pierre Delord, et al.Cancers|February 21, 2020
Dickkopf-2 (DKK2) as Context Dependent Factor in Patients with Esophageal AdenocarcinomaLars M Schiffmann, Heike Loeser, Anne Sophie Jacob, et al.BMC Cancer|June 2, 2019
Elevated X-linked inhibitor of apoptosis protein (XIAP) expression uncovers detrimental prognosis in subgroups of neoadjuvant treated and T-cell rich esophageal adenocarcinomaLars M Schiffmann, Heike Göbel, Heike Löser, et al.Plos One|January 12, 2013
Prognostic impact of [18F]fluorothymidine and [18F]fluoro-D-glucose baseline uptakes in patients with lung cancer treated first-line with erlotinibMatthias Scheffler, Thomas Zander, Lucia Nogova, et al.Journal of Cancer Research and Clinical Oncology|July 5, 2021
Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysisPatrick Sven Plum, Alexander Damanakis, Lisa Buschmann, et al.Frontiers in Oncology|August 9, 2021
Occurrence of High Microsatellite-Instability/Mismatch Repair Deficiency in Nearly 2,000 Human Adenocarcinomas of the Gastrointestinal Tract, Pancreas, and Bile Ducts: A Study From a Large German Comprehensive Cancer CenterAlexander Quaas, Jan Rehkaemper, Josef Rueschoff, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 19, 2021
Sex-specific prognostic effect of CD66b-positive tumor-infiltrating neutrophils (TANs) in gastric and esophageal adenocarcinomaAlexander Quaas, Aylin Pamuk, Sebastian Klein, et al.Journal of Cancer Research and Clinical Oncology|December 30, 2017
CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomachHarald Schmalenberg, Salah-Eddin Al-Batran, Claudia Pauligk, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 17, 2023
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancerFlorian Lordick, Salah-Eddin Al-Batran, Dirk Arnold, et al.Pageof 27